Atomo Diagnostics Ltd has released a press release.
H1 FY26 Results Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
In the deck
Story so far
Earlier from Atomo Diagnostics
- Appendix 4D and Half Year Report ended 31 Dec 2025
- Atomo Secures Australian Order for Supply of HIV Self-Tests
- Atomo Secures a Significant Order for HIV Self-Test
- Quarterly Activities/Appendix 4C Cash Flow Report
- Exclusive Licence for a Novel Liver Function Test on Pascal
Later from Atomo Diagnostics
- Response to ASX Price Query
- Pause in Trading
- Trading Halt
- FebriDx FDA CLIA wavier approval unlocks upside for Pascal
- Atomo Completes Capital Raise
Follow Atomo Diagnostics into a list and get an email when it puts out news.
Follow Atomo Diagnostics